spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

On Helix 2018

On_Helix_2018

10-11 July 2018
The Cambridge Building, Babraham Research Campus

ON Helix is One Nucleus' translational research conference for the Life Sciences industry.

ON Helix is a two-day event aimed at informing delegates of how to turn early stage inventions and ideas into innovative health treatments (new medicines, novel biomarkers, useful medical devices or improved medical practices).

The annual translational research conference, ON Helix aims to inform delegates of how to turn early stage inventions and ideas into innovative health treatments such as new medicines, novel biomarkers and medical devices, all aimed at improving medical practice. 

One Nucleus’ flagship Cambridge conference has moved to the Babraham Research Campus and is now a two day event. The growth of the conference allows for greater opportunities to debate the key challenges along the journey from discovery to first in man. 

Keynote Sessions will kick off both days. Each day will then break off into three parallel streams, consisting of panel debates, case studies, deal showcases, scientific talks and fireside chats. Day One will culminate with a Plenary Session and Conference Drinks Reception, open to ALL conference delegates. A great opportunity to meet those that may otherwise be attending a different day!  

Full details of the conference can be found at onhelix.com

phone +44 (0) 1223 896 450
email info@onenucleus.com
web onenucleus.com
email The Cambridge Building, Babraham Research Campus
 
Print this page
Send to a friend
   
spacer
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>


White Papers

Six Strategies to Stretch Your Limited Drug Supply for Clinical Studies

PCI Pharma Services

Bringing a new drug to market can be a heavy financial burden on any pharmaceutical company. It has become even more burdensome over the last several years as the industry pushes the boundaries of innovation. This is because newer, often more-complex therapies not only increase risk in drug development but also drive costs even higher. A recent analysis of the investment needed to develop a new prescription medicine shows the total cost can be as high as $2.6 billion (1). That number becomes even more staggering when you consider the fact that only about 12 percent of drug candidates that make it to Phase I testing are eventually approved by the FDA (2). The investment companies lose as a result may be too devastating to their bottom line to ever recover.
More info >>


News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement